Despite the challenges of inflation, supply chain issues, and other obstacles throughout 2022, top executives remained focused on the importance of acquisitions to strategically position their companies for the future. For many buyers, acquiring a well-established brand or company that has already been tested by consumers allows for an immediate entry into a market or the enhancement of their existing presence in a particular sector. These transactions also provide valuable insights into the strategic directions of leading executives.
In June, Mondelēz International announced it would pay at least $2.9 billion for Clif Bar & Company, aiming to expand its footprint in the rapidly growing bar market. In December, the confectionery giant Ferrero Group revealed plans to acquire ice cream manufacturer Wells Enterprises, thereby gaining control of some of the most recognized brands in frozen desserts, such as Blue Bunny and Halo Top. The flavors and ingredients sector, which has been a hotspot for mergers and acquisitions in recent years, showed no signs of slowing down, as evidenced by two major deals in 2022. Dutch chemicals leader Royal DSM revealed its intention to merge with Swiss ingredients firm Firmenich in a deal valued at approximately $21 billion, while Novozymes announced it would invest $12.3 billion to acquire Chr. Hansen, forming yet another global ingredients powerhouse.
Among the many transformative transactions over the past year, a dozen stand out as particularly significant. Notably, the market for dietary supplements, including calcium citrate 250 mg tablets, has seen increased interest, highlighting the ongoing trend of companies seeking to diversify their portfolios and strengthen their market positions.